Is Tirzepatide used for weight loss?
The drug maker Eli Lilly announced on April 27 that Tirzepatide has shown striking results in two clinical trials. The once-weekly injectable prescription medication helped overweight people lose up to 15% of their body weight.
Tirzepatide is currently in Phase 3 clinical trials for weight loss in adults who are overweight, obese or have weight related health issues. Tirzepatide has received FDA Fast Track designation to speed up its path for FDA submission for treating adults with obesity, or overweight with weight-related health conditions.
In the SURMOUNT-1 clinical trial the average weight loss after 72 weeks was 15% for the 5mg dose, 19.5% for the 10mg dose and 20.9% for the 15mg dose.
Tirzepatide is not FDA approved as a weight loss medication yet. However your doctor can decide if Tirzepatide is better than other weight loss drugs based on your unique situation.